Biotech Companies Explore GLP-1 Weight-Loss Drugs for Overweight Cats
Recent developments in veterinary medicine indicate that GLP-1 weight-loss treatments, similar to those used for humans, are being tested for overweight cats, potentially transforming pet healthcare and creating new market opportunities for biotech and pet food companies.